← Leaderboards
Ravikanth Metlapally
University Of California Berkeley
$827,130
Attributed
$827,130
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.4K · FY2012–16$200K$150K$100K$50K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$827,130 · 1
By mechanism
K08$827,130 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- Christine Frances Wildsoet$7,292,496
- Anthony J Adams$9,217,712
- Lisa A Ostrin$5,975,921
- Lin He$13,893,779
- Kenneth A Polse$8,601,122
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAnimalsAffectAreaBaseBioinformaticsBiomedical EngineeringApoptosisBioreactorsBruch&AposCareer DevelopmentCell ProliferationChoroidCollagenCostDesignDevelopment PlansBiometryEconomic ImpactEffective TherapyEnvironmentEpigenetic ProcessEtiologyExtracellular Matrix
Grant awards (5)
Micro-RNAs in the Sclera: Role in Ocular Growth, and Implications for Myopia$165,426
K08 · FY2016 · EY · contact PI
Micro-RNAs in the Sclera: Role in Ocular Growth, and Implications for Myopia$165,426
K08 · FY2015 · EY · contact PI
Micro-RNAs in the Sclera: Role in Ocular Growth, and Implications for Myopia$165,426
K08 · FY2014 · EY · contact PI
Micro-RNAs in the Sclera: Role in Ocular Growth, and Implications for Myopia$165,426
K08 · FY2013 · EY · contact PI
Micro-RNAs in the Sclera: Role in Ocular Growth, and Implications for Myopia$165,426
K08 · FY2012 · EY · contact PI